Cargando…

Proteasome inhibition by bortezomib: A left hook and a right punch

Detalles Bibliográficos
Autor principal:	Roelofs, Jeroen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534694/ https://www.ncbi.nlm.nih.gov/pubmed/26288826 http://dx.doi.org/10.1016/j.ebiom.2015.07.009

Ejemplares similares

Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
por: Kraus, M, et al.
Publicado: (2013)

Ascarosides from helminths pack a punch against allergy
por: Maizels, Rick M.
Publicado: (2022)

Bortezomib Amplifies Effect on Intracellular Proteasomes by Changing Proteasome Structure()
por: Pitcher, David S., et al.
Publicado: (2015)

The resistance mechanisms of proteasome inhibitor bortezomib
por: Lü, Shuqing, et al.
Publicado: (2013)

The one-two punch: Retinoic acid suppresses obesity both by promoting energy expenditure and by inhibiting adipogenesis
por: Noy, Noa
Publicado: (2013)

Genetically Linked Scientists: The One-Two Punch for Nfatp Knockout
por: Caplan, Arnold I., et al.
Publicado: (2000)

Punching above their weight: a network to understand broader determinants of increasing life expectancy
por: Baum, Fran, et al.
Publicado: (2018)

Case report of right hamate hook fracture in a patient with previous fracture history of left hamate hook: is it hamate bipartite?
por: Evans, Marion W, et al.
Publicado: (2006)

Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy
por: Boccadoro, Mario, et al.
Publicado: (2005)

Proteasome Inhibitor Bortezomib Ameliorates Intestinal Injury in Mice
por: Yanaba, Koichi, et al.
Publicado: (2012)

Alterations of the Intracellular Peptidome in Response to the Proteasome Inhibitor Bortezomib
por: Gelman, Julia S., et al.
Publicado: (2013)

Hooked on the nicotine addiction thesis: a response to DiFranza
por: Dar, Reuven, et al.
Publicado: (2013)

Vascular Spasm: A Newly Unraveled Cause for Cardiovascular Adversity of Proteasome Inhibition
por: Wang, Xuejun
Publicado: (2017)

Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib
por: Steverding, Dietmar, et al.
Publicado: (2009)

Metformin Induces Resistance of Cancer Cells to the Proteasome Inhibitor Bortezomib
por: Schlesser, Camille, et al.
Publicado: (2022)

Analysis of the Influence of Blanking Clearance on the Wear of the Punch, the Change of the Burr Size and the Geometry of the Hook Blanked in the Hardened Steel Sheet
por: Mucha, Jacek, et al.
Publicado: (2019)

Feasibility of Long-term Proteasome Inhibition in Multiple Myeloma by in-class Transition From Bortezomib to Ixazomib
por: Manda, Sudhir, et al.
Publicado: (2020)

Proteasome activator Blm10 levels and autophagic degradation directly impact the proteasome landscape
por: Burris, Alicia, et al.
Publicado: (2021)

The Sandy Hook Elementary School shooting as tipping point: “This Time Is Different”
por: Shultz, James M, et al.
Publicado: (2013)

Combined Effect of Bortezomib and Menadione Sodium Bisulfite on Proteasomes of Tumor Cells: The Dramatic Decrease of Bortezomib Toxicity in a Preclinical Trial
por: Astakhova, Tatiana M., et al.
Publicado: (2018)

Elemene sensitizes pancreatic cancer cells to bortezomib by enhancing proteasome inhibition via molecular patch mechanism
por: Hou, Shurong, et al.
Publicado: (2023)

Effect of the specific proteasome inhibitor bortezomib on cancer‐related muscle wasting
por: Penna, Fabio, et al.
Publicado: (2015)

Bortezomib-resistance is associated with increased levels of proteasome subunits and apoptosis-avoidance
por: Wu, Yi-Xin, et al.
Publicado: (2016)

The ubiquitin–proteasome system as a molecular target in solid tumors: an update on bortezomib
por: Milano, A, et al.
Publicado: (2009)

Proteasome inhibition, the pursuit of new cancer therapeutics, and the adaptor molecule p130Cas
por: Chauhan, Dharminder, et al.
Publicado: (2011)

Mind the gap: closure of right to left shunts for rare indications
por: ten Cate, T. J. F., et al.
Publicado: (2018)

Commentary: Supporting a left ventricular assist device to transplant, the right way
por: Ising, Mickey S., et al.
Publicado: (2022)

Pharmacodynamic monitoring of (immuno)proteasome inhibition during bortezomib treatment of a critically ill patient with lupus nephritis and myocarditis
por: de Groot, Karina A, et al.
Publicado: (2015)

Phosphorylation of the C-terminal tail of proteasome subunit α7 is required for binding of the proteasome quality control factor Ecm29
por: Wani, Prashant S., et al.
Publicado: (2016)

The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis
por: van Dijk, Marianne, et al.
Publicado: (2011)

Hypoxia Enhances the Senescence Effect of Bortezomib—The Proteasome Inhibitor—On Human Skin Fibroblasts
por: Krętowski, Rafał, et al.
Publicado: (2014)

Proteasome stress sensitizes malignant pleural mesothelioma cells to bortezomib-induced apoptosis
por: Cerruti, Fulvia, et al.
Publicado: (2017)

Overcoming Proteasome Inhibitor-Refractory Multiple Myeloma With Elotuzumab, Bortezomib, Nelfinavir, and Dexamethasone
por: Erath, Alexandra, et al.
Publicado: (2020)

The Proteasome Inhibitor Bortezomib Induces Apoptosis and Activation in Gel-Filtered Human Platelets
por: Ghansah, Harriet, et al.
Publicado: (2021)

Bortezomib Warhead-Switch Confers Dual Activity against Mycobacterial Caseinolytic Protease and Proteasome and Selectivity against Human Proteasome
por: Moreira, Wilfried, et al.
Publicado: (2017)

Upregulation of Protein Synthesis and Proteasome Degradation Confers Sensitivity to Proteasome Inhibitor Bortezomib in Myc-Atypical Teratoid/Rhabdoid Tumors
por: Tran, Huy Minh, et al.
Publicado: (2020)

How many neurons does it take to tell left from right?
por: Al‐Asmar, Alid, et al.
Publicado: (2022)

A unique case of right cervical aortic arch with anomalous left common carotid artery and absent right common carotid artery
por: Guha, Soumya, et al.
Publicado: (2016)

Punch Trackers: Correct Recognition Depends on Punch Type and Training Experience
por: Omcirk, Dan, et al.
Publicado: (2021)

Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitors
por: Franke, Niels E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8k4fhufhhbpvahvq07gj00vl60